LOGIN
Perioperative Intravenous Dexamethasone After Unilateral Elective Hip Arthroscopy
August 2024
Perioperative Intravenous Dexamethasone After Unilateral Elective Hip Arthroscopy
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Perioperative Intravenous Dexamethasone Significantly Reduces Postoperative Opioid Requirement and Nausea After Unilateral Elective Hip Arthroscopy: A Randomized Double-blinded Placebo-controlled Trial.
Am J Sports Med . 2024 Apr;52(5):1165-1172.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Fifty patients undergoing unilateral elective hip arthroscopy were randomized to receive either intravenous dexamethasone (n=27) or a placebo (n=23). The primary outcome of interest was postoperative pain. Secondary outcomes included opioid consumption, nausea scores, vomiting events, and adverse events up to 12 weeks postoperatively. Outcomes were assessed at 6 hours postoperatively and on postop...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.